Cart is empty Reducing the burden of sickle cell disease (SCD) requires substantial financial and political commitment to improving dataccollection, diagnosis, treatment and training. Doing so will positively impact the lives of millions of patients and families worldwide—says a new Commission published in The Lancet Haematology journal.
Leave A Comment